Pharmacological separation of the expression of tissue transglutaminase and apoptosis after chemotherapeutic treatment of HepG2 cells

Molecular Pharmacology

Volumn 59, Issue 6, 2001, Pages 1388-1394

  Uray, I P ^a   Davies, P J A ^a   Fesus L ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

6 [1 (5,6,7,8 TETRAHYDRO 3,5,5,8,8 PENTAMETHYL 2 NAPHTHYL)CYCLOPROPYL]NICOTINIC ACID; BLEOMYCIN; CASPASE 3; CISPLATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FAS ANTIGEN; GENE PRODUCT; GLYCOPROTEIN GP 130; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID; PROTEIN BAX; PROTEIN BCL X; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 0034986420     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.6.1388     Document Type: Article

References (36)

1. Protein crosslinking in assembly and remodelling of extracellular matrices: The role of transglutaminases
2. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents
3. Lack of induction of tissue transglutaminase but activation of the preexisting enzyme in c-Myc-induced apoptosis of CHO cells
4. Stress pathways and heart failure
5. Apoptosis of epithelial cells in vivo involves tissue transglutaminase upregulation
6. Induction and activation of tissue transglutaminase during programmed cell death
7. Signals through gp130 upregulate bcl-x gene expression via STAT1- binding cis-element in cardiac myocytes
8. Proliferation-dependent vs. independent programmed cell death of prostatic cancer cells involves distinct gene regulation
9. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: Effects on cellular morphology and adhesion
10. The effects of bleomycin and copper bleomycin upon transglutaminase enzymes
11. Hydrogen peroxide mediates doxorubicin-induced transglutaminase 2 expression in PC-14 human lung cancer cell line
12. Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line
13. Transcriptional regulation of the human FasL promoter-enhancer region
14. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch
15. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1
16. Interleukin-6 is a survival factor for committed myeloid progenitor cells
17. TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells
18. Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines
19. Transglutaminases
20. High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells
21. Tissue transglutuminase and apoptosis: Sense and antisense transfection studies with human neuroblastoma cells
22. 'Tissue' transglutaminase in cell death: A downstream or a multifunctional upstream effector?
23. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB
24. Gh: A GTP-binding protein with transglutaminase activity and receptor signaling function
25. Caspases: Killer proteases
26. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
27. Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells
28. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
29. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
30. Transglutaminase may mediate certain physiological effects of endogenous amines and of amine-containing therapeutical agents
31. Fas-signaling and effects on receptor tyrosine kinase signal transduction in human breast epithelial cells
32. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver
33. Cells containing factor XIIIa and pulmonary fibrosis induced by bleomycin
34. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations
35. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells
36. Cleavage of Bax enhances its cell death function